<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="6801">Metformin</z:chebi> is an effective anti-hyperglycaemic and cardioprotective agent, but a long list of contraindications precludes millions of patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> from using it </plain></SENT>
<SENT sid="1" pm="."><plain>This is largely due to the historical experience of <z:hpo ids='HP_0003128'>lactic acidosis</z:hpo> with phenformin, despite the fact that <z:chebi fb="0" ids="6801">metformin</z:chebi> does not predispose to this when compared with other therapies </plain></SENT>
<SENT sid="2" pm="."><plain>Contraindications such as old age, <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e> and <z:hpo ids='HP_0001635'>cardiac insufficiency</z:hpo> are increasingly disregarded in clinical practice, yet there is no evidence that the incidence of <z:hpo ids='HP_0003128'>lactic acidosis</z:hpo> has changed </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="6801">Metformin</z:chebi> has been shown to improve metabolic control without causing <z:hpo ids='HP_0003128'>lactic acidosis</z:hpo> in elderly patients with multiple comorbidities, including explicit contraindications, and its use in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> over the age of 70 with mild <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e> did not produce a clinically relevant increase in plasma <z:chebi fb="4" ids="24996">lactate</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>There is no correlation between levels of <z:chebi fb="0" ids="6801">metformin</z:chebi> and <z:chebi fb="4" ids="24996">lactate</z:chebi> in patients with <z:hpo ids='HP_0003128'>lactic acidosis</z:hpo>, and its prognosis is mainly related to the causal hypoxic underlying disease and comorbidities </plain></SENT>
<SENT sid="5" pm="."><plain>These findings raise doubts about the pathogenetic significance of <z:chebi fb="0" ids="6801">metformin</z:chebi> in <z:hpo ids='HP_0003128'>lactic acidosis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>We propose that advanced age per se, mild <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e> and compensated <z:hpo ids='HP_0001635'>heart failure</z:hpo> can no longer be upheld as contraindications for <z:chebi fb="0" ids="6801">metformin</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>A clear re-definition of contraindications to <z:chebi fb="0" ids="6801">metformin</z:chebi> will enable more physicians to prescribe within guidelines </plain></SENT>
</text></document>